Developments in Tooling Inspections and Technology - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Developments in Tooling Inspections and Technology
Inspecting punches and dies can be time-consuming and costly for tablet manufacturers. Advances in technology, however, have greatly improved in-process inspections. The author examines improvements in equipment and computer software for in-process tool inspections.


Pharmaceutical Technology


Conclusion

Improvements in tooling management and inspection have been long overdue, and advances in technology bring the tool room into the 21st century. What was once a costly and time-consuming process that often involved storing paper in a file has become an efficient procedure for capturing valuable tooling data that can be used to improve tablet quality. The once-difficult task of analyzing working lengths, the most critical punch dimension, is now incorporated into the inspection process. An entire database of tooling data can be created and maintained with little effort and used to provide information, tool forecasting, and historical analysis. Automated and noncontact inspection systems reduce the risk of punch-tip damage from handling or scratches during the inspection process. Magnified images that highlight tool conditions can be circulated for improved troubleshooting. At last, tool-control functions are using technology to help the tablet manufacturer produce better quality tablets more efficiently.

Robert Caruso is the software support manager at Natoli Engineering, 28 Research Park Circle, St. Charles, MO 63304, tel. 636.926.8900, fax 636.926.8910,

References

1. Tableting Specification Manual, L. Young Ed. (American Pharmacists Association, Washington, DC, 7th edition, 2006).

2. Encyclopedia of Pharmaceutical Technology, Thermal Analysis of Drugs and Drug Products to Unit Processes in Pharmacy: Fundamentals (Vol. 15), J. Swarbrick and J. Boylan, Eds. (Marcel Dekker, New York, 1997).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
35%
Breakthrough designations
12%
Protecting the supply chain
35%
Expedited reviews of drug submissions
12%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
USP Faces New Challenges
Source: Pharmaceutical Technology,
Click here